» Articles » PMID: 21921973

Molecular Architecture of G Protein-Coupled Receptors

Overview
Journal Drug Dev Res
Specialty Pharmacology
Date 2011 Sep 17
PMID 21921973
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

This review of the current literature on mutations in G protein-coupled receptors (GPCRs) of the rhodopsin-related family intends to draw inferences from amino acid sequences for single receptors and multiple sequence alignments with regard to the molecular architecture of this class of receptors. For this purpose a comprehensive list of mutations within the transmembrane helical regions (TMs; over 390 mutations from 38 different receptor subtypes) and their effects on function was compiled, and an alignment of known GPCR sequences (over 150 separate sequences) was made. Regions most prominently involved in ligand binding are located in TMs 3, 5, 6, and 7. Position 3.32 in TM3 is occupied by a D in all biogenic amine receptors (sequence conservation) but may be occupied by uncharged residues in other receptors while its role in ligand binding is analogous (function conservation). TMs 5, 6, and 7 display considerable sequence conservation throughout the majority of GPCRs investigated, but not necessarily at those positions involved in ligand binding. However, considerable function conservation is observed for positions 5.42 (frequently hydrophilic), 5.46 (small amino acids required for agonist binding to "small ligand" receptors), 6.52 and 7.39 (high variability), and 7.43 (frequently aromatic). A general conclusion of this review is that there is overwhelming conservation of structure-function correlates among GPCRs. Thus, it is now possible to cross-correlate the results of mutagenesis studies between GPCRs of different subfamilies, and to use those results to predict the function of specific residues in new GPCR sequences.

Citing Articles

Molecular basis of human trace amine-associated receptor 1 activation.

Zilberg G, Parpounas A, Warren A, Yang S, Wacker D Nat Commun. 2024; 15(1):108.

PMID: 38168118 PMC: 10762035. DOI: 10.1038/s41467-023-44601-4.


Molecular Basis of Human Trace Amine-Associated Receptor 1 Activation.

Zilberg G, Parpounas A, Warren A, Yang S, Wacker D bioRxiv. 2023; .

PMID: 37986760 PMC: 10659437. DOI: 10.1101/2023.09.06.556555.


Synthesis, Biological Evaluation, and Docking Studies of Antagonistic Hydroxylated Arecaidine Esters Targeting mAChRs.

Kilian J, Millard M, Ozenil M, Krause D, Ghaderi K, Holzer W Molecules. 2022; 27(10).

PMID: 35630651 PMC: 9145622. DOI: 10.3390/molecules27103173.


Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M Antagonists.

Kilian J, Ozenil M, Millard M, Furtos D, Maisetschlager V, Holzer W Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215360 PMC: 8879200. DOI: 10.3390/ph15020248.


Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization.

Salmaso V, Jain S, Jacobson K Methods Cell Biol. 2021; 166:133-159.

PMID: 34752329 PMC: 8620127. DOI: 10.1016/bs.mcb.2021.06.001.


References
1.
Strader C, Candelore M, HILL W, Sigal I, Dixon R . Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J Biol Chem. 1989; 264(23):13572-8. View

2.
Baldwin J . The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 1993; 12(4):1693-703. PMC: 413383. DOI: 10.1002/j.1460-2075.1993.tb05814.x. View

3.
Strader C, Dixon R, Cheung A, Candelore M, Blake A, Sigal I . Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. J Biol Chem. 1987; 262(34):16439-43. View

4.
Dalziel H, Westfall D . Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev. 1994; 46(4):449-66. View

5.
Elling C, Nielsen S, Schwartz T . Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. Nature. 1995; 374(6517):74-7. DOI: 10.1038/374074a0. View